SEC Form 4 · accession 0001144204-16-120761
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur Przybyl
Officer — President and CEO · Director
Period of report
Aug 22, 2016
Accepted (ET)
Aug 23, 2016 · 4:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 22, 2016 | M | 24,705 | $6.36 | A | 200,788 | D | |
| Common Stock | Aug 22, 2016 | M | 15,723 | $6.36 | A | 216,511 | D | |
| Common Stock | Aug 22, 2016 | M | 12,750 | $33.00 | A | 229,261 | D | |
| Common StockF1 | Aug 22, 2016 | S | 37,455 | $66.97 | D | 191,806 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $6.36 | Aug 22, 2016 | M | 24,705 | A | Jul 11, 2013 | Jul 11, 2023 | Common Stock | 24,705 | 39,682 | D |
| Stock Options | $6.36 | Aug 22, 2016 | M | 15,723 | A | Jul 11, 2013 | Jul 11, 2023 | Common Stock | 15,723 | 23,959 | D |
| Stock Options | $33.00 | Aug 22, 2016 | M | 12,750 | A | Mar 31, 2014 | Mar 31, 2024 | Common Stock | 12,750 | 12,750 | D |
Explanation of responses
- F1The reported price is a weighted average sale price for multiple sale transactions ranging from a low sale price of $66.70 to a high sale price of $67.57. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request from the staff of the Securities and Exchange Commission, the Issuer or a stockholder of the Issuer.